Evotec and Medicines For Malaria announce a long-term compound management collaboration
Evotec announced the start of a multi-year compound management agreement between Evotec (U.S.) and Medicines for Malaria Venture in support of MMV’s Malaria and Pathogen Box initiatives. These initiatives are expected to revolutionise the field of drug discovery for malaria and neglected diseases. August 19, 2014